204 related articles for article (PubMed ID: 29205930)
1. Post-diagnosis weight loss as a prognostic factor in non-small cell lung cancer.
Mytelka DS; Li L; Benoit K
J Cachexia Sarcopenia Muscle; 2018 Feb; 9(1):86-92. PubMed ID: 29205930
[TBL] [Abstract][Full Text] [Related]
2. Impact of Socioeconomic Status on Pretreatment Weight Loss and Survival in Non-Small-Cell Lung Cancer.
Lau SKM; Gannavarapu BS; Carter K; Gao A; Ahn C; Meyer JJ; Sher DJ; Jatoi A; Infante R; Iyengar P
J Oncol Pract; 2018 Apr; 14(4):e211-e220. PubMed ID: 29558251
[TBL] [Abstract][Full Text] [Related]
3. Quality of life and survival survey of cancer cachexia in advanced non-small cell lung cancer patients-Japan nutrition and QOL survey in patients with advanced non-small cell lung cancer study.
Takayama K; Atagi S; Imamura F; Tanaka H; Minato K; Harada T; Katakami N; Yokoyama T; Yoshimori K; Takiguchi Y; Hataji O; Takeda Y; Aoe K; Kim YH; Yokota S; Tabeta H; Tomii K; Ohashi Y; Eguchi K; Watanabe K
Support Care Cancer; 2016 Aug; 24(8):3473-80. PubMed ID: 27003901
[TBL] [Abstract][Full Text] [Related]
4. Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index.
Martin L; Birdsell L; Macdonald N; Reiman T; Clandinin MT; McCargar LJ; Murphy R; Ghosh S; Sawyer MB; Baracos VE
J Clin Oncol; 2013 Apr; 31(12):1539-47. PubMed ID: 23530101
[TBL] [Abstract][Full Text] [Related]
5. Weight loss over time and survival: a landmark analysis of 1000+ prospectively treated and monitored lung cancer patients.
Le-Rademacher J; Lopez C; Wolfe E; Foster NR; Mandrekar SJ; Wang X; Kumar R; Adjei A; Jatoi A
J Cachexia Sarcopenia Muscle; 2020 Dec; 11(6):1501-1508. PubMed ID: 32940014
[TBL] [Abstract][Full Text] [Related]
6. Cancer cachexia, sarcopenia and biochemical markers in patients with advanced non-small cell lung cancer-chemotherapy toxicity and prognostic value.
Srdic D; Plestina S; Sverko-Peternac A; Nikolac N; Simundic AM; Samarzija M
Support Care Cancer; 2016 Nov; 24(11):4495-502. PubMed ID: 27236439
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive validation of the functional assessment of anorexia/cachexia therapy (FAACT) anorexia/cachexia subscale (A/CS) in lung cancer patients with involuntary weight loss.
Gelhorn HL; Gries KS; Speck RM; Duus EM; Bourne RK; Aggarwal D; Cella D
Qual Life Res; 2019 Jun; 28(6):1641-1653. PubMed ID: 30796591
[TBL] [Abstract][Full Text] [Related]
8. Hypermetabolism is an independent prognostic factor of survival in metastatic non-small cell lung cancer patients.
Jouinot A; Ulmann G; Vazeille C; Durand JP; Boudou-Rouquette P; Arrondeau J; Tlemsani C; Fournel L; Alifano M; Wislez M; Chapron J; Le Bris C; Mansuet-Lupo A; Damotte D; Neveux N; De Bandt JP; Alexandre J; Cynober L; Goldwasser F
Clin Nutr; 2020 Jun; 39(6):1893-1899. PubMed ID: 31443979
[TBL] [Abstract][Full Text] [Related]
9. The applicability of a weight loss grading system in cancer cachexia: a longitudinal analysis.
Vagnildhaug OM; Blum D; Wilcock A; Fayers P; Strasser F; Baracos VE; Hjermstad MJ; Kaasa S; Laird B; Solheim TS;
J Cachexia Sarcopenia Muscle; 2017 Oct; 8(5):789-797. PubMed ID: 28627024
[TBL] [Abstract][Full Text] [Related]
10. Body composition in patients with non-small cell lung cancer: a contemporary view of cancer cachexia with the use of computed tomography image analysis.
Baracos VE; Reiman T; Mourtzakis M; Gioulbasanis I; Antoun S
Am J Clin Nutr; 2010 Apr; 91(4):1133S-1137S. PubMed ID: 20164322
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of body mass index and change in body weight in postoperative outcomes of lung cancer surgery.
Nakagawa T; Toyazaki T; Chiba N; Ueda Y; Gotoh M
Interact Cardiovasc Thorac Surg; 2016 Oct; 23(4):560-6. PubMed ID: 27252238
[TBL] [Abstract][Full Text] [Related]
12. Leptomeningeal carcinomatosis in non-small-cell lung cancer patients: impact on survival and correlated prognostic factors.
Lee SJ; Lee JI; Nam DH; Ahn YC; Han JH; Sun JM; Ahn JS; Park K; Ahn MJ
J Thorac Oncol; 2013 Feb; 8(2):185-91. PubMed ID: 23328548
[TBL] [Abstract][Full Text] [Related]
13. Prognostic impact of cancer cachexia in patients with advanced non-small cell lung cancer.
Kimura M; Naito T; Kenmotsu H; Taira T; Wakuda K; Oyakawa T; Hisamatsu Y; Tokito T; Imai H; Akamatsu H; Ono A; Kaira K; Murakami H; Endo M; Mori K; Takahashi T; Yamamoto N
Support Care Cancer; 2015 Jun; 23(6):1699-708. PubMed ID: 25430482
[TBL] [Abstract][Full Text] [Related]
14. Rapid atrophy of cardiac left ventricular mass in patients with non-small cell carcinoma of the lung.
Kazemi-Bajestani SMR; Becher H; Butts C; Basappa NS; Smylie M; Joy AA; Sangha R; Gallivan A; Kavsak P; Chu Q; Baracos VE
J Cachexia Sarcopenia Muscle; 2019 Oct; 10(5):1070-1082. PubMed ID: 31293070
[TBL] [Abstract][Full Text] [Related]
15. [Enteral nutrition in malnourished patients with lung cancer].
Pierret T; Fontaine É; Pérol M; Avrillon V; Swalduz A; Pinsolle J; Giaj-Levra M; Moro-Sibilot D; Toffart A
Rev Mal Respir; 2020 Apr; 37(4):349-351. PubMed ID: 32279889
[No Abstract] [Full Text] [Related]
16. Impact of cancer cachexia on the therapeutic outcome of combined chemoimmunotherapy in patients with non-small cell lung cancer: a retrospective study.
Morimoto K; Uchino J; Yokoi T; Kijima T; Goto Y; Nakao A; Hibino M; Takeda T; Yamaguchi H; Takumi C; Takeshita M; Chihara Y; Yamada T; Hiranuma O; Morimoto Y; Iwasaku M; Kaneko Y; Yamada T; Takayama K
Oncoimmunology; 2021; 10(1):1950411. PubMed ID: 34290909
[TBL] [Abstract][Full Text] [Related]
17. Early Weight Loss during Chemoradiotherapy Has a Detrimental Impact on Outcome in NSCLC.
Sanders KJ; Hendriks LE; Troost EG; Bootsma GP; Houben RM; Schols AM; Dingemans AM
J Thorac Oncol; 2016 Jun; 11(6):873-9. PubMed ID: 26940529
[TBL] [Abstract][Full Text] [Related]
18. Prognostic validation of the body mass index, airflow obstruction, dyspnea, and exercise capacity (BODE) index in inoperable non-small-cell lung cancer.
Denehy L; Hornsby WE; Herndon JE; Thomas S; Ready NE; Granger CL; Valera L; Kenjale AA; Eves ND; Jones LW
J Thorac Oncol; 2013 Dec; 8(12):1545-50. PubMed ID: 24389436
[TBL] [Abstract][Full Text] [Related]
19. The Role of a Cachexia Grading System in Patients with Non-Small Cell Lung Cancer Treated with Immunotherapy: Implications for Survival.
Turcott JG; Martinez-Samano JE; Cardona AF; Bassarmal SS; Ramírez-Tirado LA; Zatarain-Barrón ZL; Barrón F; Corrales L; Martín C; Barragán-Castillo PA; Ruiz-Patiño A; Flores-Estrada D; Arrieta O
Nutr Cancer; 2021; 73(5):794-801. PubMed ID: 32482104
[TBL] [Abstract][Full Text] [Related]
20. Body mass index, C-reactive protein and survival in smokers undergoing lobectomy for lung cancer†.
Nagata M; Ito H; Matsuzaki T; Furumoto H; Isaka T; Nishii T; Yokose T; Nakayama H
Eur J Cardiothorac Surg; 2017 Jun; 51(6):1164-1170. PubMed ID: 28199511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
